Predicting outcomes in patients with R/R MM undergoing CAR T-cell therapy: the MyCARe model Published 2024-02-16 Download video MP4 360p Recommendations 06:43 Should JAK2 VAF testing be implemented as routine in risk assessment and disease monitoring in MPN? 03:57 What is chronic lymphocytic leukaemia? 01:58 MRD as a surrogate endpoint for AML therapy 01:30 Cardiovascular risk factors and pulmonary hypertension in patients with MPNs 04:45 Orthopaedics in Oxford 20:32 Never Smoked to STAGE 4 LUNG CANCER! - Lindsay | Stage 4b Lung Cancer | The Patient Story 29:03 VÁCLAV MORAVEC: Pravé peklo nás teprve čeká, maďarské cestě se nevyhneme 01:13 The main treatment goals in LR-MDS and how these differ from HR-MDS 01:28 Studying Bloom Syndrome 02:49 What are the side effects of immunotherapy? 31:35 Breakthroughs in Aging Research | Dr. Eric Verdin, 2024 Longevity Summit | Aviv Clinics 31:52 RADEK PTÁČEK: Někteří lidé prostě volí zlo, změní jim to mozek a necítí vinu Similar videos 39:28 New horizons in R/R follicular lymphoma: risk stratification & practicalities of CAR T-cell therapy 25:53 Clinical experience of IgM IgA enriched immuno globulin in the treatment. Wah-tak tsang Kenneth 56:20 RGH MGR 5 28 2020 1:01:00 COVID-19: Impact on Caring for Your Patients With Hematologic Malignancies - Episode 3 1:00:23 RGH MGR 1 28 2021 1:22:19 A Closer Look At...Prostate Cancer Treatments 57:33 ICD-10 Training: Orthopedics 1:12:07 Myeloma Crowd Radio: Melanie House, DPT, NCS, University of Iowa 1:04:24 AI Aspirations Healthcare Futures | DoM Grand Rounds | 2 August 2023 7:33:16 May 24, 2024 Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 11:46:57 The First Thing I Did After Being Reborn into the Apocalypse Was to Jump from the 99th Floor！ More results